Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort study

O'Brien J, et al. Insertion of PICCs with minimum number of lumens reduces complications and costs. J Am Coll Radiol. 2013;10:864–8.

Gibson C, et al. Peripherally inserted central catheters: use at a tertiary care pediatric center. J Vasc Interv Radiol. 2013;24:1323–31.

Aw A, et al. Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res. 2012;130(3):323–6.

Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21(19):3665–75.

Chopra V, et al. The problem with peripherally inserted central catheters. JAMA. 2012;308:1527–8.

Chopra V, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382:311–25.

Lobo BL, et al. Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. J Hosp Med. 2009;4:417–22.

Liem TK, et al. Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg. 2012;55(3):761–7.

Sperry BW, Roskos M, Oskoui R. The effect of laterality on venous thromboembolism formation after peripherally inserted central catheter placement. J Vasc Access. 2012;13(1):91–5.

Evans RS, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010;138(4):803–10.

Winters JP, et al. Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the medical inpatients and thrombosis (MITH) study. J Thromb Haemost. 2015;13(12):2155–60.

Fallouh N, et al. Peripherally inserted central catheter-associated deep vein thrombosis: a narrative review. Am J Med. 2015;128(7):722–38.

Saber W, et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2011;9(2):312–9.

Chemaly RF, et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis. 2002;34(9):1179–83.

Cortelezzia A, et al. Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma. 2003;44(9):1495–501.

King MM, et al. Peripherally inserted central venous catheter-associated thrombosis: retrospective analysis of clinical risk factors in adult patients. South Med J. 2006;99(10):1073–7.

Paauw JD, et al. The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants. JPEN J Parenter Enteral Nutr. 2008;32(4):443–7.

Itkin M, et al. Peripherally inserted central catheter thrombosis – reverse tapered versus nontapered catheters: a randomized controlled study. J Vasc Interv Radiol. 2014;25(1):85–91.

Loughran SC, et al. Peripherally inserted central catheters: a report of 2,506 catheter days. JPEN J Parenter Enteral Nutr. 1995;19(2):133–6.

Kamphuisen PW,et al. Catheter-related thrombosis: lifeline or a pain in the neck? Hematology Am Soc Haematol Educ Program. 2012;2012:638–44.

Liu Y, et al. Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation 2015;11:153–160.

Nifong TP, McDevitt TJ. The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters. Chest. 2011;140:48–53.

Song L, et al. Malposition of peripherally inserted central catheter: experience from 3012 cancer patients. Int J Nurs Pract. 2014;20:446–9.

Ackerknecht EH. Rudolf Virchow. Doctor, statesman, anthropologist. Madison, WI: University of Wisconsin, Madison; 1953.

Gallieni M, et al. Vascular access in oncology patients. CA Cancer J Clin. 2008;58(6):323–46.

Grove JR, et al. Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol. 2000;11(7):837–40.

Evans RS, et al. Reduction of peripherally inserted central catheter-associated DVT. Chest. 2013;143(3):627–33.

Cotogni P, et al. Focus on peripherally inserted central catheters in critically ill patients. World J Crit Care Med. 2014;3(4):80–94.

Lee AY, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol. 2006;24(9):1404–8.

Walshe LJ, et al. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002;20(15):3276–81.

Ng PK, et al. Peripherally inserted central catheters in general medicine. Mayo Clin Proc. 1997;72(3):225–33.

Ong B, et al. Peripherally inserted central catheters and upper extremity deep vein thrombosis. Australas Radiol. 2006;50(5):451–4.

Cheng YJ, Liu ZH, Yao FJ, et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013;10(9):e1001515.

Lee KW, Lip GYH. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med. 2003;163(19):2368–92.

Yarnell JW, Sweetnam PM, Rumley A, Lowe GD. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly study. Arterioscler Thromb Vasc Biol. 2000;20:271–9.

Oger E, Lacut K, Van Dreden P, et al. High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly. Haematologica. 2003;88:465–9.

Feher MD, Rampling MW, Brown J, et al. Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J R Soc Med. 1990;83(3):146–8.

Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the third National Health and nutrition examination survey. PLoS Med. 2005;2(6):e160.

Haire WD, et al. Hickman catheter-induced thoracic vein thrombosis: frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer. 1990;66:900–8.

Blom JW, et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost. 2006;4(3):529–35.

Polk A, et al. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacol Toxicol. 2014;15:47.

Manuel Monreal. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study Chest 1991; 99(2).

Monreal M. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines--a prospective study. Thromb Haemost. 1994;72(4).

Chin EE, et al. Sonographic evaluation of upper extremity deep venous thrombosis. J Ultrasound Med. 2005;24(6):829–38.

Karthaus M, et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol. 2006;17(2):289–96.

Young AM, et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet. 2009;373(9663):567–74.

Akl EA, et al. Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev. 2014;10:CD006468.